All Publications by Topic
Menstrual Cycles and Reproductive History
Body Size and Physical Activity
Alcohol, Smoking, Diet
Medication
Environmental Exposures
Breast Cancer Subtypes
Genetic Mutations
Gene-Environment Interactions
Race and Breast Cancer
Epidemiologic Methods
Menstrual Cycles and Reproductive History
Rockhill B, Moorman PG, Newman B. Age at menarche, time to regular cycling, and risk of breast cancer. Cancer Causes and Control: 447-53, 1998.Abstract
Furberg H, Newman B, Moorman P, Millikan R. Lactation and breast cancer risk. International Journal of Epidemiology 28: 396-402, 1999. Abstract PDF
Marcus P, Baird D, Millikan R, Moorman P, Qaqish B, Newman B. Adolescent reproductive events and subsequent breast cancer risk. American Journal of Public Health 89: 1244-47, 1999. Abstract PDF
Huang W-Y, Newman B, Millikan R, Schell M, Hulka B, Moorman P. Hormone-related factors and risk of breast cancer by estrogen receptor and progesterone receptor status. American Journal of Epidemiology (US) 151(7): 703-714, 2000. Abstract PDF
Moorman P, Millikan R, Newman B. Oral contraceptives and breast cancer among African-American women and white women. Journal of the National Medical Association. 9: 329-34 (2001). Abstract PDF
Moorman P, Kuwabara H, Millikan R, Newman B. Menopausal hormones and breast cancer in a biracial population. American Journal of Public Health 90(6): 966-971.Abstract PDF
Furberg H, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Reproductive factors in relation to breast cancer characterized by p53 protein expression (US). Cancer Causes and Control. 14: 609-18, 2003. Abstract
dos Santos Silva I, DeStavola B, McCormack V. Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer. Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. 5(9): e193, 2008 Abstract PDF
Phillips L, Millikan R, Shroeder J, Rockhill B, Barnholtz-Sloan J. Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiology, Biomarkers and Prevention. 18. 1507-14, 2009. Abstract
Body Size and Physical Activity
Hall IJ, Newman B, Millikan R, Moorman P. Body size and breast cancer risk in black women and white women. American Journal of Epidemiology 151(8): 754-764, 2000. Abstract PDF
Moorman P, Jones B, Millikan R, Hall I, Newman B. Race, Anthropometric Factors and Stage at Diagnosis of Breast Cancer. American Journal of Epidemiology 153: 284-91, 2001. Abstract PDF
Marcus P, Newman B, Moorman B, Millikan R, Baird D, Qaqish B, Sternfeld B. Physical activity at age 12 and adult breast cancer risk (United States). Cancer Causes and Control: 10(4): 293-302, 1999. Abstract
Alcohol, Smoking, and Diet
Millikan RC, Pittman GS, Newman B, Tse C-KJ, Selmin O, Rockhill B, Savitz D, Moorman PG, Bell DA. Cigarette smoking, N-acetyltransferases 1 and 2 and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 7: 826-833, 1998. Abstract PDF
Marcus P, Newman B, Moorman P, Millikan R, Baird D, Qaqish B. The associations of adolescent cigarette smoking, alcoholic beverage consumption and environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes and Control 151(7) 703-14, 2000. Abstract
Kinney AY, Millikan RC, Lin YH, Moorman PG, Newman B. Alcohol consumption and breast cancer among black and white women in North Carolina. Cancer Causes and Control (Netherlands) 11(4): 345-357, 2000. Abstract
Tseng M, Yeatts K, Millikan R, Newman B. Area-level characteristics and smoking in women. American Journal of Public Health 91. 1847-50 (2001). Abstract PDF
Moorman P, Ricciuti M, Millikan R, Newman B. Vitamin and mineral supplements and breast cancer risk. Results from the Carolina Breast Cancer Study. Public Health and Nutrition 4: 821, 2001. Abstract PDF
Li Y, Millikan R, Bell D, Cui L, Tse C-K, Newman B, Conway K. Cigarette smoking, cytochrome P4501A1 (CYP1A1) polymorphisms, and breast cancer among African Americans and white women. Breast Cancer Research 6: 460-473, 2004. Abstract PDF
Medication
Moorman P, Grubber J, Millikan RC, Newman B. Anti-depressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology 14: 307-14, 2003. Abstract
Moorman P, Grubber J, Millikan R, Newman B. Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes and Control 14: 915-922, 2003. Abstract
Moorman P. Associations of aspirin use and hormone receptor status with breast cancer risk. Journal of the American Medical Association. 292: 1426, 2004. Excerpt
Moorman P, Sesay J, Nwosu V, Kane J, de Cotret A, Worley K, Millikan R. COXR Polymorphism (Val511Ala), NSAID Use and Breast Cancer in African-American Women. Cancer Epidemiology, Biomarkers and Prevention 14: 3013-14, 2005.Abstract PDF
Environmental Exposures
Schildkraut J, Demark-Wahnefried DeVoto E, Hughes C, Laseter J, Newman B. Environmental contaminants and body fat distribution. Cancer Epidemiology, Biomarkers and Prevention 8: 179-83, 1999.Abstract PDF
Marcus P, Newman B, Moorman P, Millikan R, Baird D, Qaqish B. The associations of adolescent cigarette smoking, alcoholic beverage consumption and environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes and Control 151(7) 703-14, 2000.Abstract
Duell E, Millikan R, Savitz D, Newman B, Smith J, Schell M, Sandler D. A population-based case control study of farming and breast cancer in North Carolina. Epidemiology 11(5): 523-531, 2000. Abstract PDF
Duell E, Millikan R, Savitz D, Schell M, Newman B, Tse C-K, Sandler D. Reliability of reported farming activities and pesticide use in a case-control study of breast cancer in North Carolina. Annals of Epidemiology 11: 178-85, 2001. Abstract
Millikan R, DeVoto E, Duell E, Tse C-K, Savitz D, Beach J, Edmiston S, Jackson S, Newman B. DDEs, PCBs, and breast cancer: a case-control study of African-American and white women. Cancer Epidemiology, Biomarkers and Prevention 9: 567-73, 2001. Abstract PDF
Van Wijngaarden E, Nylander-French L, Millikan R, Savitz D, Loomis D. Population-based case-control study of occupational exposure to electromagnetic fields and female breast cancer. Annals of Epidemiology 11: 297-303. 2001. Abstract
Cooper G, Savitz D, Millikan R, Tse C-K. Organochlorine exposure and age at natural menopause. Epidemiology 13: 729-33, 2002. Abstract
Furberg H, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Environmental Factors in Relation to Breast Cancer Characterized by p53 Protein Expression. Cancer Epidemiology, Biomarkers and Prevention 11: 829-35, 2002. Abstract PDF
Breast Cancer Subtypes
Carey L, Perou C, Livasy C, Dressler L, Cowan D, Conway K, Karaca G, Troester M, Tse C-K, Edmiston S, Deming S, Geradts J, Cheang M, Nielson T, Moorman P, Earp H, Millikan R. Race, Breast Cancer Subtypes and Survival in the Carolina Breast Cancer Study. Journal of the American Medical Association 295: 2492-2502, 2006. Abstract PDF
Livasy C, Perou C, Karaca G, Cowan D, Maria D, Jackson S, Tse C-K, Millikan RC. Identification of a basal-like subtype of breast ductal carcinoma in situ. Human Pathology. 38:197-204, 2007. Abstract
Millikan R, Newman B, Tse C-K, Moorman P, Conway K, Smith L, Labbok M, Geradts J, Bensen, Jackson S, Nyante S, Livasy C, Carey L, Earp H, Perou Epidemiology of basal-like breast cancer. Breast Cancer Research and Treatment 190: 123-139, 2008 Abstract
Thorner A, Hoadley K, Parker J, Winkel S, Millikan R, and Perou C. In vitro and in vivo analysis of B-Myb in basal-like breast cancer Oncogene 28: 742-51, 2009 Abstract PDF
Genetic Markers
Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King M-C. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279: 915-921, 1998.Abstract PDF
Millikan RC, Pittman GS, Tse CKJ, Duell E, Newman B, Savitz D, Moorman PG, Boissy RJ, Bell DA. Catechol-O-methyltransferase (COMT) and breast cancer risk. Carcinogenesis 19: 1943-47, 1998.Abstract PDF
Li Y, Millikan R, Tse C-KJ, Newman B, Conway K, Liu ET. Germline P57 polymorphisms and risk of breast cancer. Human Genetics 104: 83-88, 1999. Abstract
Huang W-Y, Newman B, Millikan R, Conway K, Hulka B, Schell M, Liu E. Risk of breast cancer according to the status of Her-2/neu oncogene amplification. Cancer Epidemiology, Biomarkers and Prevention (US) 9(1): 65-71, 2000. Abstract PDF
Millikan RC. NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. Cancer Epidemiology, Biomarkers, and Prevention 9(2): 217-9, 2000. Abstract PDF
Duell E, Millikan R, Pittman G, Winkel S, Lunn R, Tse C-K, Eaton A, Mohrenweiser H, Newman B, Bell D. XRCC1 polymorphisms and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 10: 567-573, 2000. Abstract PDF
Millikan R, Pittman G, Tse C-K, Savitz D, Newman B, Bell D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiology, Biomarkers and Prevention 9(6): 567- 573, 2000. Abstract PDF
Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang W-Y, Geradts J, Iacocca M, Cowan D, Conway K, Dressler L. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Research and Treatment 79: 355-64, 2003. Abstract
Canter J, Kallianpur A, Parl F, Millikan R. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Research 65: 8028-33, 2005. Abstract PDF
Millikan R, Player J, de Cotret AR, Moorman P, Pittman G, Vannappagari V, Tse C-K, Keku T. Manganese Superoxide Dismutase (MnSOD) Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Research 6: 264-274, 2004. Abstract PDF
Millikan R, Hummer A, Wolff M, Begg C. HER2 codon 655 polymorphism and breast cancer: Results from kin-cohort and case-control analyses. Breast Cancer Research and Treatment. 89: 309-12, 2005. Abstract
Conway K, Parrish E, Edmiston S, Tolbert D, Tse J, Geradts J, Livasy C, Singh H, Newman B, Millikan R. The estrogen receptor alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population based study. Breast Cancer Research 7: R871-880, 2005. PDF
Lark A, Livasy C, Millikan R, Tse C-K, Moore D, Cowan D, Dressler L, Little D, Craven R, Cancer W. High FAK expression in invasive breast carcinomas is associated with aggressive phenotype. Modern Pathology 18: 1289-94, 2005. Abstract PDF
Millikan R, Heard K, Winkel S, Hill E, Heard K, Massa B, Mayes L, Williams P, Holston R, Conway K, Edmiston S, De Cotret AR. No association between the MDM2-309 T/G promoter polymorphism and breast cancer in African Americans or whites. Cancer Epidemiology, Biomarkers and Prevention 15: 175-77, 2006.Abstract PDF
Conway K, Parrish E, Edmiston S, Tolbert D, Tse C-K, Moorman P, Newman B, Millikan R. Risk Factors for Breast Cancer Characterized by the Estrogen Receptor Alpha A908G (K303R) Mutation. Breast Cancer Research 9: R36, 2007. PDF
Gene-Environmental Interactions
Millikan RC, Pittman GS, Newman B, Tse C-KJ, Selmin O, Rockhill B, Savitz D, Moorman PG, Bell DA. Cigarette smoking, N-acetyltransferases 1 and 2 and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 7: 826-833, 1998. Abstract PDF
Conway K, Edmiston S, Cui L, Drouin S, Pang J, He M, Tse C-K, Geradts J, Dressler L, Liu E, Millikan R, Newman B. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Research 62: 1987-95, 2002. Abstract PDF
Furberg H, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Environmental Factors in Relation to Breast Cancer Characterized by p53 Protein Expression. Cancer Epidemiology, Biomarkers and Prevention 11: 829-35, 2002. Abstract PDF
Li Y, Millikan R, Bell D, Cui L, Tse C-K, Newman B, Conway K. Cigarette smoking, cytochrome P4501A1 (CYP1A1) polymorphisms, and breast cancer among African Americans and white women. Breast Cancer Research 6: 460-473, 2004. Abstract PDF
Millikan R, Player J, deCotret A, Tse C-K, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 14: 2326-34, 2005. Abstract PDF
Moorman P, Sesay J, Nwosu V, Kane J, de Cotret A, Worley K, Millikan R. COXR Polymorphism (Val511Ala), NSAID Use and Breast Cancer in African-American Women. Cancer Epidemiology, Biomarkers and Prevention 14: 3013-14, 2005.Abstract PDF
Mechanic L, Millikan R, Player J, Rene de Cotret A, Winkel S, Worley K, Heard K, Tse C-K, Keku T. Polymorphisms in Nucleotide Excision Repair Genes, Smoking and Breast Cancer in African Americans and Whites: A Population-Based Case-Control Study. Carcinogenesis 27: 1377-85, 2006. Abstract PDF
Pachkowski B, Winkel S, Kubota Y, Swenberg J, Millikan R, Nakamura J. XRCC1 genotype and breast cancer: Functional studies and epidemiologic data demonstrate interactions between XRCC1 codon 280 His and smoking. Cancer Research 66: 2876-77, 2006. Abstract PDF
Race and Breast Cancer
Dunmore C, Plummer P, Regan G, Mattingly D, Jackson S, Millikan R. Re: Race and differences in breast cancer survival in a managed care population. Journal of National Cancer Institute 92: 1690-91, 2000. Abstract PDF
Kinney AY, Millikan RC, Lin YH, Moorman PG, Newman B. Alcohol consumption and breast cancer among black and white women in North Carolina. Cancer Causes and Control (Netherlands) 11(4): 345-357, 2000. Abstract
Moorman P, Millikan R, Newman B. Oral contraceptives and breast cancer among African-American women and white women. Journal of the National Medical Association. 9: 329-34 (2001). Abstract PDF
Moorman P, Jones B, Millikan R, Hall I, Newman B. Race, Anthropometric Factors and Stage at Diagnosis of Breast Cancer. American Journal of Epidemiology 153: 284-91, 2001. Abstract PDF
Furberg H, Millikan R, Dressler L, Newman B, Geradts J. Tumor characteristics in African American and white women. Breast Cancer Research and Treatment 68: 33-43 2001. Abstract
Millikan R, DeVoto E, Duell E, Tse C-K, Savitz D, Beach J, Edmiston S, Jackson S, Newman B. DDEs, PCBs, and breast cancer: a case-control study of African-American and white women. Cancer Epidemiology, Biomarkers and Prevention 9: 567-73, 2001. Abstract PDF
Moorman P, Kuwabara H, Millikan R, Newman B. Menopausal hormones and breast cancer in a biracial population. American Journal of Public Health 90(6): 966-971.Abstract PDF
Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang W-Y, Geradts J, Iacocca M, Cowan D, Conway K, Dressler L. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Research and Treatment 79: 355-64, 2003. Abstract
Millikan R, Player J, de Cotret AR, Moorman P, Pittman G, Vannappagari V, Tse C-K, Keku T. Manganese Superoxide Dismutase (MnSOD) Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Research 6: 264-274, 2004. Abstract PDF
Li Y, Millikan R, Bell D, Cui L, Tse C-K, Newman B, Conway K. Cigarette smoking, cytochrome P4501A1 (CYP1A1) polymorphisms, and breast cancer among African Americans and white women. Breast Cancer Research 6: 460-473, 2004. Abstract PDF
Hall I, Moorman P, Millikan R, and Newman B. Comparative analysis of breast cancer risk factors among African-American women and white women. American Journal of Epidemiology 161: 40-51, 2005. Abstract PDF
Moorman P, Sesay J, Nwosu V, Kane J, de Cotret A, Worley K, Millikan R. COXR Polymorphism (Val511Ala), NSAID Use and Breast Cancer in African-American Women. Cancer Epidemiology, Biomarkers and Prevention 14: 3013-14, 2005.Abstract PDF
Canter J, Kallianpur A, Parl F, Millikan R. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Research 65: 8028-33, 2005. Abstract PDF
Moorman P, Sesay J, Nwosu V, Kane J, de Cotret A, Worley K, Millikan R. COXR Polymorphism (Val511Ala), NSAID Use and Breast Cancer in African-American Women. Cancer Epidemiology, Biomarkers and Prevention 14: 3013-14, 2005.Abstract PDF
Mechanic L, Millikan R, Player J, Rene de Cotret A, Winkel S, Worley K, Heard K, Tse C-K, Keku T. Polymorphisms in Nucleotide Excision Repair Genes, Smoking and Breast Cancer in African Americans and Whites: A Population-Based Case-Control Study. Carcinogenesis 27: 1377-85, 2006. Abstract PDF
Carey L, Perou C, Livasy C, Dressler L, Cowan D, Conway K, Karaca G, Troester M, Tse C-K, Edmiston S, Deming S, Geradts J, Cheang M, Nielson T, Moorman P, Earp H, Millikan R. Race, Breast Cancer Subtypes and Survival in the Carolina Breast Cancer Study. Journal of the American Medical Association 295: 2492-2502, 2006. Abstract PDF
Millikan R, Heard K, Winkel S, Hill E, Heard K, Massa B, Mayes L, Williams P, Holston R, Conway K, Edmiston S, De Cotret AR. No association between the MDM2-309 T/G promoter polymorphism and breast cancer in African Americans or whites. Cancer Epidemiology, Biomarkers and Prevention 15: 175-77, 2006. Abstract PDF
Millikan R, Newman B, Tse C-K, Moorman P, Conway K, Smith L, Labbok M, Geradts J, Bensen, Jackson S, Nyante S, Livasy C, Carey L, Earp H, Perou Epidemiology of basal-like breast cancer. Breast Cancer Research and Treatment 190: 123-139, 2008 Abstract
Epidemiologic Methods
Newman B, Moorman PG, Millikan. R, Qaqish BF, Geradts J, Aldrich TE, Lui ET. The Carolina Breast Cancer Study: Integrating population-based epidemiology and molecular biology. Breast Cancer Research and Treatment 35: 51-60, 1995. Abstract
Millikan R, DeVoto E, Newman B, Savitz D. Studying environment influences and breast cancer risk: Suggestions for an integrated population-based approach. Breast Cancer Research and Treatment 35: 70-89, 1995. Abstract
Rockhill B, Newman B, Weinberg C. Uses and abuses of population attributable fraction. American Journal of Public Health 88: 15-19, 1998. PDF
Lin D, Zeng D, Millikan R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genetic Epidemiology, 29: 299-312, 2005. Abstract
